Effects of Salbutamol in Athletes and Implications for Screening and Sports

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Asthma, Healthy, Effect of Drug

In brief

β2-Agonists, commonly used to treat asthma, have also been used by athletes to enhance performance, leading to their ban by the International Olympic Committee in 1972. Research has shown non-asthmatics receive no benefit from these drugs at therapeutic dosages; however, many elite athletes still use them, and asthmatic athletes often win more Olympic medals. In some non-asthmatics, β2-agonists may improve breathing limitations during high intensity exercise, which may improve performance. Therefore, we aim to examine if there is a select group of non-asthmatic individuals who experience breathing limitations that may receive benefit from β2-agonists.

Key facts

Study ID
NCT07037511
Run by
University of British Columbia
People needed
64
Starts
2025-10-30
Expected to finish
2030-12-31
Last updated by the study team
2026-03-13

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.